Alaunos Therapeutics Inc (TCRT) — Financial Flexibility Index
Alaunos Therapeutics Inc (TCRT) has a Financial Flexibility Index of -0.68x as of December 2025. Free cash flow of $-551.00K (operating CF $-552.00K minus capex $1.00K) represents -1% of total liabilities ($813.00K). Check TCRT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alaunos Therapeutics Inc Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Alaunos Therapeutics Inc across 25 annual periods. See Alaunos Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Alaunos Therapeutics Inc (2001–2025)
Year-by-year free cash flow to debt coverage for Alaunos Therapeutics Inc. For the full company profile including market capitalisation, see TCRT market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.41x | $-2.77 Million | $-2.87 Million | $813.00K | ▲ +52.6% |
| 2024 | -7.18x | $-4.97 Million | $-4.97 Million | $692.00K | ▲ +53.1% |
| 2023 | -15.31x | $-29.95 Million | $-30.14 Million | $1.96 Million | ▼ -1292.0% |
| 2022 | -1.10x | $-29.02 Million | $-29.23 Million | $26.38 Million | ▲ +30.4% |
| 2021 | -1.58x | $-58.15 Million | $-61.47 Million | $36.81 Million | ▲ +25.2% |
| 2020 | -2.11x | $-47.23 Million | $-57.01 Million | $22.36 Million | ▲ +26.6% |
| 2019 | -2.88x | $-40.57 Million | $-40.85 Million | $14.10 Million | ▲ +44.3% |
| 2018 | -5.16x | $-49.00 Million | $-49.46 Million | $9.49 Million | ▼ -1838.4% |
| 2017 | -0.27x | $-53.93 Million | $-54.67 Million | $202.41 Million | ▲ +15.3% |
| 2016 | -0.31x | $-57.77 Million | $-58.33 Million | $183.65 Million | ▼ -5292.6% |
| 2015 | 0.01x | $402.00K | $-10.00K | $66.35 Million | ▲ +100.2% |
| 2014 | -3.20x | $-36.46 Million | $-36.65 Million | $11.40 Million | ▼ -20.5% |
| 2013 | -2.65x | $-59.38 Million | $-59.51 Million | $22.37 Million | ▼ -20.1% |
| 2012 | -2.21x | $-77.27 Million | $-78.83 Million | $34.96 Million | ▼ -114.1% |
| 2011 | -1.03x | $-37.68 Million | $-38.84 Million | $36.50 Million | ▼ -63.9% |
| 2010 | -0.63x | $-19.51 Million | $-19.69 Million | $30.97 Million | ▼ -10.9% |
| 2009 | -0.57x | $-12.28 Million | $-12.29 Million | $21.63 Million | ▲ +85.8% |
| 2008 | -4.01x | $-23.39 Million | $-23.52 Million | $5.83 Million | ▼ -21.9% |
| 2007 | -3.29x | $-20.91 Million | $-21.65 Million | $6.36 Million | ▲ +30.3% |
| 2006 | -4.72x | $-14.07 Million | $-14.42 Million | $2.98 Million | ▼ -25.0% |
| 2005 | -3.78x | $-8.65 Million | $-8.78 Million | $2.29 Million | ▼ -987.0% |
| 2004 | -0.35x | $-7.31K | $-7.31K | $21.05K | ▲ +4.2% |
| 2003 | -0.36x | $-9.33K | $-9.33K | $25.72K | ▲ +43.5% |
| 2002 | -0.64x | $-11.45K | $-11.77K | $17.84K | ▲ +88.3% |
| 2001 | -5.50x | $-30.26K | $-30.26K | $5.50K | — |